Is conservative organ-sparing treatment of penile carcinoma justified?

European Urology

Volumn 38, Issue 3, 2000, Pages 306-312

  Gotsadze, David ^a   Matveev, Boris ^b   Zak, Boris ^c   Mamaladze, Vasil ^a  

^a Georgia Oncological Research Center   (Georgia)

^b Department of Urology   (Russian Federation)

^c Department of Urology   (Russian Federation)

Author keywords

Conservative treatment; Long term follow up results; Penile carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSERVATIVE TREATMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PENIS CARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0033846639     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020298     Document Type: Article

References (51)